Skip to main content
logo
Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
32.74
+0.10 (0.31%)
At close: Oct 8, 2025, 4:00 PM EDT
32.51
-0.23 (-0.70%)
After-hours: Oct 8, 2025, 6:52 PM EDT

Revenue by Product

Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Reimbursement
138.35M
Log In
Log In
Log In
Log In
Upgrade
Reimbursement Growth
-28.16%
Log In
Log In
Log In
Log In
Upgrade
Milestone
138.90M
Log In
Log In
Log In
Log In
Upgrade
Milestone Growth
-
Log In
Log In
Log In
Log In
Upgrade
License
277.81K
Log In
Log In
Log In
Log In
Upgrade
Other
242.11M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
93.98%
Log In
Log In
Log In
Log In
Upgrade
DARZALEX Royalties
1.93B
Log In
Log In
Log In
Log In
Upgrade
DARZALEX Royalties Growth
21.89%
Log In
Log In
Log In
Log In
Upgrade
Kesimpta Royalties
308.65M
Log In
Log In
Log In
Log In
Upgrade
Kesimpta Royalties Growth
37.07%
Log In
Log In
Log In
Log In
Upgrade
TEPEZZA Royalties
102.37M
Log In
Log In
Log In
Log In
Upgrade
TEPEZZA Royalties Growth
-0.45%
Log In
Log In
Log In
Log In
Upgrade
Other Product Royalties
65.42M
Log In
Log In
Log In
Log In
Upgrade
Other Product Royalties Growth
51.14%
Log In
Log In
Log In
Log In
Upgrade
Collaboration
60.15M
Log In
Log In
Log In
Log In
Upgrade
Collaboration Growth
28.33%
Log In
Log In
Log In
Log In
Upgrade
Net Product Sales
242.11M
Log In
Log In
Log In
Log In
Upgrade
Net Product Sales Growth
93.29%
Log In
Log In
Log In
Log In
Upgrade
J&J
2.00B
Log In
Log In
Log In
Log In
Upgrade
J&J Growth
20.29%
Log In
Log In
Log In
Log In
Upgrade
Novartis
391.99M
Log In
Log In
Log In
Log In
Upgrade
Novartis Growth
66.25%
Log In
Log In
Log In
Log In
Upgrade
BioNTech
120.71M
Log In
Log In
Log In
Log In
Upgrade
BioNTech Growth
-32.63%
Log In
Log In
Log In
Log In
Upgrade
Pfizer
74.04M
Log In
Log In
Log In
Log In
Upgrade
Pfizer Growth
22.64%
Log In
Log In
Log In
Log In
Upgrade
Other Collaboration Partner
277.81K
Log In
Log In
Log In
Log In
Upgrade
Other Collaboration Partner Growth
-
Log In
Log In
Log In
Log In
Upgrade
Roche
102.93M
Log In
Log In
Log In
Log In
Upgrade
Roche Growth
1.10%
Log In
Log In
Log In
Log In
Upgrade
AbbVie
54.73M
Log In
Log In
Log In
Log In
Upgrade
AbbVie Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Denmark
2.75B
Log In
Log In
Log In
Log In
Upgrade
Denmark Growth
-
Log In
Log In
Log In
Log In
Upgrade
United States
125.29M
Log In
Log In
Log In
Log In
Upgrade
Japan
116.82M
Log In
Log In
Log In
Log In
Upgrade